Your Advocates Ltd’s DexCom DXCM Stock Holding History

Your Advocates Ltd’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.96K	Hold	44	–	–	﹤0.01%	166
2026 Q1	$2.76K	Hold	44	–	–	﹤0.01%	171
2025 Q4	$2.92K	Hold	44	–	–	﹤0.01%	171
2025 Q3	$2.96K	Hold	44	–	–	﹤0.01%	159
2025 Q2	$3.84K	Hold	44	–	–	﹤0.01%	143
2025 Q1	$3K	Hold	44	–	–	﹤0.01%	152
2024 Q4	$3.42K	Hold	44	–	–	﹤0.01%	147
2024 Q3	$2.95K	Hold	44	–	–	﹤0.01%	169
2024 Q2	$4.99K	Hold	44	–	–	﹤0.01%	146
2024 Q1	$6.1K	Hold	44	–	–	﹤0.01%	131
2023 Q4	$5.46K	Hold	44	–	–	﹤0.01%	132
2023 Q3	$4.11K	Hold	44	–	–	﹤0.01%	160
2023 Q2	$5.65K	Hold	44	–	–	﹤0.01%	165
2023 Q1	$5.11K	Hold	44	–	–	﹤0.01%	131
2022 Q4	$4.98K	Hold	44	–	–	﹤0.01%	116
2022 Q3	$4K	Hold	44	–	–	﹤0.01%	119
2022 Q2	$3K	Hold	44	–	–	﹤0.01%	139
2022 Q1	$6K	Hold	44	–	–	﹤0.01%	122
2021 Q4	$6K	Hold	44	–	–	﹤0.01%	112
2021 Q3	$6K	Buy	+44	New	+$5.55K	﹤0.01%	112

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

DCP

DSM Capital Partners Palm Beach Gardens, Florida $5.84B AUM 22.63% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Your Advocates Ltd's DXCM Position: Q2 2026 in Review

Your Advocates Ltd held its DexCom (DXCM) position steady in Q2 2026 at 44 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #166.

Your Advocates Ltd first reported a position in DXCM in Q3 2021 and has held it in 20 quarters since. The position peaked at $6.1K in Q1 2024. 495 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Your Advocates Ltd held 44 shares of DexCom worth $2.96K as of Q2 2026.
Your Advocates Ltd left its DexCom share count unchanged in Q2 2026.
DexCom made up ﹤0.01% of Your Advocates Ltd's portfolio in Q2 2026, its #166 holding.
Your Advocates Ltd first reported a position in DexCom in Q3 2021 and has held it in 20 quarters since.
Your Advocates Ltd's DexCom position peaked at $6.1K in Q1 2024.
495 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Your Advocates Ltd's 13F filing for Q2 2026, filed 5 Aug 2026.